These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38831091)

  • 1. Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials.
    Ogoyama Y; Abe M; Okamura K; Tada K; Katsurada K; Shibata S; Kai H; Rakugi H; Node K; Yokoi H; Kario K; Arima H
    Hypertens Res; 2024 Oct; 47(10):2745-2759. PubMed ID: 38831091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.
    Ogoyama Y; Tada K; Abe M; Nanto S; Shibata H; Mukoyama M; Kai H; Arima H; Kario K
    Hypertens Res; 2022 Feb; 45(2):210-220. PubMed ID: 34657140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials.
    Yang X; Liu H; Chen S; Dong P; Zhao D
    Kidney Blood Press Res; 2022; 47(6):363-374. PubMed ID: 35385842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.
    Wang J; Yin Y; Lu C; Lu Z; Hu J; Wang Y; Ge J; Jiang H; Yao C; Yan X; Ma W; Qi X; Dang Y; Chen S; Zhu J; Wang D; Ding C; Wang W; Liu J; Wang Y; Li H; Pan Z; Cui K; Li C; Liang X; Chen W; Sobotka PA; Zhang J; Esler M; Sun N; Chen M; Huo Y
    EClinicalMedicine; 2024 Jun; 72():102626. PubMed ID: 38756107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysis.
    Vukadinović D; Lauder L; Kandzari DE; Bhatt DL; Kirtane A; Edelman ER; Schmieder RE; Azizi M; Böhm M; Mahfoud F
    medRxiv; 2024 Jun; ():. PubMed ID: 38946962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial.
    Kario K; Mahfoud F; Kandzari DE; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Brar S; Hettrick DA; Fahy M; Böhm M
    Hypertens Res; 2023 Jan; 46(1):280-288. PubMed ID: 36241705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis.
    Fadl Elmula FEM; Feng YM; Jacobs L; Larstorp AC; Kjeldsen SE; Persu A; Staessen JA;
    Blood Press; 2017 Aug; 26(4):195-203. PubMed ID: 28443356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis.
    Fernandes A; David C; Pinto FJ; Costa J; Ferreira JJ; Caldeira D
    BMC Cardiovasc Disord; 2023 May; 23(1):249. PubMed ID: 37173636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
    Böhm M; Mahfoud F; Townsend RR; Kandzari DE; Pocock S; Ukena C; Weber MA; Hoshide S; Patel M; Tyson CC; Weil J; Agdirlioglu T; Fahy M; Kario K
    Eur Heart J; 2019 Mar; 40(9):743-751. PubMed ID: 30608521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE; Weber MA; Pathak A; Zidar JP; Saxena M; David SW; Schmieder RE; Janas AJ; Langer C; Persu A; Mendelsohn FO; Ameloot K; Foster M; Fischell TA; Parise H; Mahfoud F
    Circulation; 2024 Jun; 149(24):1875-1884. PubMed ID: 38587557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension.
    Wang TD; Lee YH; Chang SS; Tung YC; Yeh CF; Lin YH; Pan CT; Hsu CY; Huang CY; Wu CK; Sung PH; Chiang LT; Wang YC; Tsai WC; Lin TT; Lin CP; Chen WJ; Hwang JJ
    Acta Cardiol Sin; 2019 May; 35(3):199-230. PubMed ID: 31249454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON; Vase H; Bech JN; Christensen KL; Buus NH; Schroeder AP; Lederballe O; Rickers H; Kampmann U; Poulsen PL; Hansen KW; Btker HE; Peters CD; Engholm M; Bertelsen JB; Lassen JF; Langfeldt S; Andersen G; Pedersen EB; Kaltoft A
    J Hypertens; 2016 Aug; 34(8):1639-47. PubMed ID: 27228432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation in hypertension: An updated meta-analysis of the randomized controlled trials.
    Singh S; Rout A; Garg A
    Catheter Cardiovasc Interv; 2023 Oct; 102(4):663-671. PubMed ID: 37545184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.
    Böhm M; Tsioufis K; Kandzari DE; Kario K; Weber MA; Schmieder RE; Townsend RR; Kulenthiran S; Ukena C; Pocock S; Ewen S; Weil J; Fahy M; Mahfoud F
    J Am Coll Cardiol; 2021 Sep; 78(10):1028-1038. PubMed ID: 34474735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.
    Pathak A; Rudolph UM; Saxena M; Zeller T; Müller-Ehmsen J; Lipsic E; Schmieder RE; Sievert H; Halbach M; Sharif F; Parise H; Fischell TA; Weber MA; Kandzari DE; Mahfoud F
    EuroIntervention; 2023 Sep; 19(7):602-611. PubMed ID: 37427416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.
    Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Lobo MD; Sharp ASP; Bloch MJ; Basile J; Wang Y; Saxena M; Lurz P; Rader F; Sayer J; Fisher NDL; Fouassier D; Barman NC; Reeve-Stoffer H; McClure C; Kirtane AJ;
    Circulation; 2019 May; 139(22):2542-2553. PubMed ID: 30880441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation.
    Azizi M; Daemen J; Lobo MD; Mahfoud F; Sharp ASP; Schmieder RE; Wang Y; Saxena M; Lurz P; Sayer J; Bloch MJ; Basile J; Weber MA; Rump LC; Levy T; Sapoval M; Sanghvi K; Rader F; Fisher NDL; Gosse P; Abraham J; Claude L; Barman NC; McClure CK; Liu Y; Kirtane AJ;
    JACC Cardiovasc Interv; 2020 Dec; 13(24):2922-2933. PubMed ID: 33357531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study.
    Gosse P; Cremer A; Kirtane AJ; Lobo MD; Saxena M; Daemen J; Wang Y; Stegbauer J; Weber MA; Abraham J; Kario K; Bangalore S; Claude L; Liu Y; Azizi M
    Hypertension; 2021 Feb; 77(2):529-536. PubMed ID: 33356403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of renal denervation on resistant hypertension: Meta-analysis of randomized controlled clinical trials.
    Yao Y; Zhang D; Qian J; Deng S; Huang Y; Huang J
    Clin Exp Hypertens; 2016; 38(3):278-86. PubMed ID: 27018652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.
    Azizi M; Saxena M; Wang Y; Jenkins JS; Devireddy C; Rader F; Fisher NDL; Schmieder RE; Mahfoud F; Lindsey J; Sanghvi K; Todoran TM; Pacella J; Flack J; Daemen J; Sharp ASP; Lurz P; Bloch MJ; Weber MA; Lobo MD; Basile J; Claude L; Reeve-Stoffer H; McClure CK; Kirtane AJ;
    JAMA; 2023 Feb; 329(8):651-661. PubMed ID: 36853250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.